OBJECTIVE: Classification criteria for systemic sclerosis (SSc; scleroderma) are being updated. Our objective was to select a set of items potentially useful for the classification of SSc using consensus procedures, including the Delphi and nominal group techniques (NGT). METHODS: Items were identified through 2 independent consensus exercises performed by the Scleroderma Clinical Trials Consortium and the European League Against Rheumatism Scleroderma Trials and Research Group. The first-round items from both exercises were collated and redundancies were removed, leaving 168 items. A 3-round Delphi exercise was performed using a 1-9 scale (where 1 = completely inappropriate and 9 = completely appropriate) and a consensus meeting using NGT was conducted. During the last Delphi round, the items were ranked on a 1-10 scale. RESULTS: In round 1, 106 experts rated the 168 items. Those with a median score of <4 were removed, resulting in a list of 102 items. In round 2, the items were again rated for appropriateness and subjected to a consensus meeting using NGT by European and North American SSc experts (n = 16), resulting in 23 items. In round 3, SSc experts (n = 26) then individually scored each of the 23 items in a last Delphi round using an appropriateness score (1-9) and ranking their 10 most appropriate items for the classification of SSc. Presence of skin thickening, SSc-specific autoantibodies, abnormal nailfold capillary pattern, and Raynaud's phenomenon ranked highest in the final list that also included items indicating internal organ involvement. CONCLUSION: The Delphi exercise and NGT resulted in a set of 23 items for the classification of SSc that will be assessed for their discriminative properties in a prospective study.
OBJECTIVE: Classification criteria for systemic sclerosis (SSc; scleroderma) are being updated. Our objective was to select a set of items potentially useful for the classification of SSc using consensus procedures, including the Delphi and nominal group techniques (NGT). METHODS: Items were identified through 2 independent consensus exercises performed by the Scleroderma Clinical Trials Consortium and the European League Against Rheumatism Scleroderma Trials and Research Group. The first-round items from both exercises were collated and redundancies were removed, leaving 168 items. A 3-round Delphi exercise was performed using a 1-9 scale (where 1 = completely inappropriate and 9 = completely appropriate) and a consensus meeting using NGT was conducted. During the last Delphi round, the items were ranked on a 1-10 scale. RESULTS: In round 1, 106 experts rated the 168 items. Those with a median score of <4 were removed, resulting in a list of 102 items. In round 2, the items were again rated for appropriateness and subjected to a consensus meeting using NGT by European and North American SSc experts (n = 16), resulting in 23 items. In round 3, SSc experts (n = 26) then individually scored each of the 23 items in a last Delphi round using an appropriateness score (1-9) and ranking their 10 most appropriate items for the classification of SSc. Presence of skin thickening, SSc-specific autoantibodies, abnormal nailfold capillary pattern, and Raynaud's phenomenon ranked highest in the final list that also included items indicating internal organ involvement. CONCLUSION: The Delphi exercise and NGT resulted in a set of 23 items for the classification of SSc that will be assessed for their discriminative properties in a prospective study.
Authors: E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim Journal: J Rheumatol Date: 1988-02 Impact factor: 4.666
Authors: Sindhu R Johnson; Jaap Fransen; Dinesh Khanna; Murray Baron; Frank van den Hoogen; Thomas A Medsger; Christine A Peschken; Patricia E Carreira; Gabriela Riemekasten; Alan Tyndall; Marco Matucci-Cerinic; Janet E Pope Journal: Arthritis Care Res (Hoboken) Date: 2012-03 Impact factor: 4.794
Authors: L S Lonzetti; F Joyal; J P Raynauld; A Roussin; J R Goulet; E Rich; D Choquette; Y Raymond; J L Senécal Journal: Arthritis Rheum Date: 2001-03
Authors: Peter A Merkel; Philip J Clements; John D Reveille; Maria E Suarez-Almazor; Gabriele Valentini; Daniel E Furst Journal: J Rheumatol Date: 2003-07 Impact factor: 4.666
Authors: D Mukerjee; D St George; B Coleiro; C Knight; C P Denton; J Davar; C M Black; J G Coghlan Journal: Ann Rheum Dis Date: 2003-11 Impact factor: 19.103
Authors: Slavica R Pavlov-Dolijanovic; Nemanja S Damjanov; Nada Z Vujasinovic Stupar; Snezana Baltic; Dragan D Babic Journal: Rheumatol Int Date: 2013-08-11 Impact factor: 2.631
Authors: Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope Journal: Arthritis Rheum Date: 2013-10-03
Authors: Pia Moinzadeh; Svetlana I Nihtyanova; Kevin Howell; Voon H Ong; Christopher P Denton Journal: Clin Rev Allergy Immunol Date: 2012-12 Impact factor: 8.667
Authors: Scott A Elman; Cara Joyce; Kara Braudis; Benjamin F Chong; Anthony P Fernandez; Fukumi Furukawa; Minoru Hasegawa; Hee Joo Kim; Sara J Li; Christine G Lian; Jacek C Szepietowski; Victoria P Werth; Joseph F Merola Journal: JAMA Dermatol Date: 2020-08-01 Impact factor: 10.282
Authors: Sara K Tedeschi; Fabio Becce; Tristan Pascart; Ali Guermazi; Jean-François Budzik; Nicola Dalbeth; Georgios Filippou; Annamaria Iagnocco; Minna J Kohler; Jean-Denis Laredo; Stacy E Smith; F Joseph Simeone; Janeth Yinh; Hyon Choi; Abhishek Abhishek Journal: Arthritis Care Res (Hoboken) Date: 2022-04-19 Impact factor: 5.178
Authors: Sindhu R Johnson; Raymond P Naden; Jaap Fransen; Frank van den Hoogen; Janet E Pope; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Christopher P Denton; Oliver Distler; Armando Gabrielli; Jacob M van Laar; Maureen Mayes; Virginia Steen; James R Seibold; Phillip Clements; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Lorinda Chung; Barri J Fessler; Peter A Merkel; Richard Silver; John Varga; Yannick Allanore; Ulf Mueller-Ladner; Madelon C Vonk; Ulrich A Walker; Susanna Cappelli; Dinesh Khanna Journal: J Clin Epidemiol Date: 2014-04-08 Impact factor: 6.437
Authors: Sara K Tedeschi; Tristan Pascart; Augustin Latourte; Cattleya Godsave; Burak Kundakci; Raymond P Naden; William J Taylor; Nicola Dalbeth; Tuhina Neogi; Fernando Perez-Ruiz; Ann Rosenthal; Fabio Becce; Eliseo Pascual; Mariano Andres; Thomas Bardin; Michael Doherty; Hang-Korng Ea; Georgios Filippou; John FitzGerald; Marwin Guitierrez; Annamaria Iagnocco; Tim L Jansen; Minna J Kohler; Frédéric Lioté; Mark Matza; Geraldine M McCarthy; Roberta Ramonda; Anthony M Reginato; Pascal Richette; Jasvinder A Singh; Francisca Sivera; Alexander So; Lisa K Stamp; Janeth Yinh; Chio Yokose; Robert Terkeltaub; Hyon Choi; Abhishek Abhishek Journal: Arthritis Care Res (Hoboken) Date: 2022-06-30 Impact factor: 5.178